Assessing response to stroke thrombolysis: Validation of 24-hour multimodal magnetic resonance imaging

Archives of Neurology

Volumn 69, Issue 1, 2012, Pages 46-50

  Campbell, Bruce C V ^a   Tu, Hans T H ^a   Christensen, Søren ^a   Desmond, Patricia M ^a   Levi, Christopher R ^b   Bladin, Christopher F ^c   Hjort, Niels ^d   Ashkanian, Mahmoud ^d   Sølling, Christine ^d   Donnan, Geoffrey A ^a   Davis, Stephen M ^a   Østergaard, Leif ^d   Parsons, Mark W ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN INFARCTION SIZE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION; STROKE; TREATMENT RESPONSE;

AGED; BRAIN INFARCTION; BRAIN MAPPING; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; INFUSIONS, INTRAVENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84155185158     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.232     Document Type: Article

References (17)

1. Albers GW, Thijs VN, Wechsler L, et al DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol. 2006;60(5):508-517. (Pubitemid 44871793)
2. Davis SM, Donnan GA, Parsons MW, et al EPITHET Investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008; 7(4):299-309.
3. Olivot JM, Mlynash M, Thijs VN, et al. Relationships between infarct growth, clinical outcome, and early recanalization in Diffusion and Perfusion Imaging for Understanding Stroke Evolution (DEFUSE). Stroke. 2008;39(8):2257-2263.
4. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. Maps of time tomaximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke. 2010;41(12):2817-2821.
5. Christensen S, Campbell BCV, Perez de la Ossa N, et al. Optimal perfusion thresholds for prediction of tissue destined for infarction in the combined EPITHET and DEFUSE dataset. Stroke. 2010;41:e297.
6. Olivot JM, Mlynash M, Thijs VN, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke. 2009;40(2):469-475.
7. Christensen S, Parsons MW, De Silva DA, et al. Testing the mismatch hypothesis in the randomized EPITHET data set: the effect of treatment, mismatch and their interaction on infarct growth. Stroke. 2010;41:e203.
8. Lansberg MG, O'Brien MW, Tong DC, Moseley ME, Albers GW. Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Arch Neurol. 2001;58(4):613-617. (Pubitemid 32295713)
9. Gaudinski MR, Henning EC, Miracle A, Luby M, Warach S, Latour LL. Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke. 2008;39(10):2765-2768.
10. Chemmanam T, Campbell BCV, Christensen S, et al EPITHET Investigators. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology. 2010;75(12):1040-1047.
11. Ebinger M, Christensen S, De Silva DA, et al Echoplanar Imaging Thrombolytic Evaluation Trial Investigators. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point. Stroke. 2009;40(4):1353-1358.
12. Parsons MW, Miteff F, Bateman GA, et al. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window. Neurology. 2009; 72(10):915-921.
13. Hacke W, Albers G, Al-Rawi Y, et al DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36(1):66-73. (Pubitemid 40054177)
14. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45(1):255-268.
15. Barrett KM, Ding YH, Wagner DP, Kallmes DF, Johnston KC; ASAP Investigators. Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy. Stroke. 2009;40(7):2422-2427.
16. Parsons MW, Christensen S, McElduff P, et al Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Pretreatment diffusion- and perfusion- MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab. 2010;30(6):1214-1225.
17. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: realworld experience and a call for action. Stroke. 2010;41(10):2254-2258.